Vida Ventures is a bicoastal venture capital firm focused on investing in life sciences, healthcare, and biotechnology companies. The firm primarily targets early to mid-stage investments, with a strong emphasis on Series A and B rounds. Vida Ventures aims to transform biomedical innovations into therapies that make a meaningful difference in patients' lives.

The firm's portfolio includes notable companies such as Allogene Therapeutics, Kronos Bio, and Kyverna Therapeutics. Vida Ventures offers value-add services to its portfolio companies, leveraging its expertise in the biomedical field to support the development of innovative therapies. The firm's investment philosophy centers on identifying and nurturing groundbreaking scientific advancements with the potential to address significant unmet medical needs.